Search filters

List of works by Camille P Vaughan

Behavioral therapy for urinary symptoms in Parkinson's disease: A randomized clinical trial

scientific article published on 11 June 2019

Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial

scientific article published on 7 November 2011

Caffeine intake and its association with urinary incontinence in United States men: results from National Health and Nutrition Examination Surveys 2005-2006 and 2007-2008.

scientific article

Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α-blocker therapy in men with nocturia

scientific article published on 28 February 2013

Increased odds of bladder and bowel symptoms in early Parkinson's disease

scientific article

Military exposure and urinary incontinence among American men.

scientific article published on 16 July 2013

Personalized Visual Mapping Assistive Technology to Improve Functional Ability in Persons With Dementia: Feasibility Cohort Study

scientific article published on 19 October 2021

Pilot Results from a Randomized Trial in Men Comparing Alpha-Adrenergic Antagonist versus Behavior and Exercise for Nocturia and Sleep

scientific article published on 28 October 2016

Prevalence and trends of symptomatic pelvic floor disorders in U.S. women.

scientific article published on January 2014

Prevalence of nocturia in United States men: results from the National Health and Nutrition Examination Survey

scientific article

Report and Research Agenda of the American Geriatrics Society and National Institute on Aging Bedside-to-Bench Conference on Urinary Incontinence in Older Adults: A Translational Research Agenda for a Complex Geriatric Syndrome.

scientific article published on 4 December 2017

Shared Risk Factors for Constipation, Fecal Incontinence, and Combined Symptoms in Older U.S. Adults.

scientific article published on 26 October 2016

The fluctuation of nocturia in men with lower urinary tract symptoms allocated to placebo during a 12-month randomized, controlled trial.

scientific article